Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.480
+0.040 (2.78%)
Nov 10, 2026, 11:21 AM EST - Market open
Enveric Biosciences Employees
As of December 31, 2025, Enveric Biosciences had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year. That makes Enveric Biosciences the 41,377th largest employer in the world and 6,363rd in the United States.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,014,755
Market Cap
6.62M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | 0 | - | 5 | 1 |
| Dec 31, 2024 | 6 | -1 | -14.29% | 5 | 1 |
| Dec 31, 2023 | 7 | -19 | -73.08% | 7 | 0 |
| Dec 31, 2022 | 26 | 2 | 8.33% | 25 | 1 |
| Dec 31, 2021 | 24 | 21 | 700.00% | 23 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Lantern Pharma | 16 |
| FibroBiologics | 15 |
| Processa Pharmaceuticals | 12 |
| Ensysce Biosciences | 10 |
| Aprea Therapeutics | 8 |
| CNS Pharmaceuticals | 8 |
| Alzamend Neuro | 6 |
ENVB News
- 6 days ago - Enveric Biosciences reports results from qEEG study of EB-003 - TheFly
- 6 days ago - Enveric Biosciences Reports Differentiated Brain Activity Profile for EB-003 in Preclinical qEEG Study - Business Wire
- 20 days ago - Enveric Biosciences announces results from IND-enabling ADMET studies - TheFly
- 20 days ago - Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies - Business Wire
- 1 month ago - Enveric receives Notice of Allowance from USPTO for application for EVM401 - TheFly
- 1 month ago - Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series - Business Wire
- 2 months ago - Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 2 months ago - Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 - Business Wire